Table 5.
Cytotoxic and genotoxic properties of Nigella sativa in vitro
| Substance | Concentration period | Period | Cell type | Main results | Reference |
|---|---|---|---|---|---|
| N. sativa oil | 0.25, 0.5, and 1 μg/mL | 95 h | Gingival fibroblasts | No cytotoxicity | [67] |
| N. sativa EE | 0–2 mg/mL | 24 h | Rat L6 muscle cell line HepG2 cell line |
EC50 >2,000 μg/mL against L6myc cell lines EC50 >1,470 μg/mL against HepG2 cell lines |
[68] |
| N. sativa EE | 100, 500, and 1,000 μg/mL | 48 h | Isolated rat splenocytes | Cytotoxic effects at 500 and 1,000 μg/mL | [57] |
| N. sativa EO and ME, PE, CE, AE, and ether extract | 10, 100, and 1,000 μg/mL | 24 h | BSL | Higher toxicity by chloroform and petroleum ether extracts. LC50 petroleum ether: 7 μg/mL LC50 chloroform: 21 μg/mL |
[69] |
| N. sativa seed VO | 500, 250, 125, and 62.5 μg/mL | Not specified | SCL, SCL-6, SCL-37′6, NUGC-4, Kato-3, 3T6 | LC50 SCL 155.02 μg/mL LC50 SCL-6 185.77 μg/mL LC50 SCL-37′6 120.40 μg/mL LC50 NUGC-4 384.53 μg/mL LC50 3T6 286.83 μg/mL |
[70] |
| N. sativa PE and AE | 670 μg/mL | 24 h | HL60 | IC50 PE 654 μg/mL IC50 AE >1,000 μg/ml |
[71] |
| N. sativa EO | 100 mg/mL | 24 h | Huh7 human cells | No cytotoxicity | [72] |
| N. sativa seed oil | 50–500 μg/mL | U-1242, U251, U-87, U-373, A172 and SNB19 | IC50 260 μg/mL | [58] | |
| AE of N. sativa | 0.5, 1, 4, 8, 9, and 18 mg/mL | Human C3A cells | Positive micronucleus test extract from Setta | [73] | |
| N. sativa seed ME, NE, and CE | 2, 2.25, 2.5, 2.75, and 3 μg/mL of methanolic, n-hexane. 0.25, 0.5, 0.75, and 1 ng/mL of chloroform |
24 h | HeLa cells | IC50 methanolic: 2.28 μg/mL IC50 n-hexane 2.20 μg/mL IC50 chloroform 0.41 ng/mL |
[74] |
| N. sativa AE | 79.5 μg/mL | 48 h | F 344 hepatocytes treated with MNNG | ↑ Chromosomal aberrations | [59] |
VO, volatile oil; FO, fixed oil; AE, aqueous extract; ME, methanol extract; CE, chloroform extract; NE, n-hexane extract; EO, essential oil; EE, ethanol extract; PE, petroleum ether extract; EC50, effective concentration; BSL, brine shrimp lethality assay; LC50, concentration that kills 50% of the cells, IC50, half-maximal inhibitory concentration inhibits 50% cell maximal growth; HL60, human myeloid leukemia cell line; MNNG, N-methyl-N-nitro-N-c.